Candidate Modifier Genes for the Penetrance of Leber's Hereditary Optic Neuropathy

被引:7
|
作者
Cheng, Hui-Chen [1 ,2 ,3 ,4 ,5 ,6 ]
Chi, Sheng-Chu [2 ]
Liang, Chiao-Ying [7 ]
Yu, Jenn-Yah [4 ,5 ,6 ]
Wang, An-Guor [2 ,3 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Coll Life Sci, Program Mol Med, Taipei 11221, Taiwan
[2] Taipei Vet Gen Hosp, Dept Ophthalmol, 201 Sec 2,Shih Pai Rd, Taipei 11217, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Ophthalmol, Taipei 11221, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Coll Life Sci, Dept Life Sci, Taipei 11221, Taiwan
[5] Natl Yang Ming Chiao Tung Univ, Coll Life Sci, Inst Genome Sci, Taipei 11221, Taiwan
[6] Natl Yang Ming Chiao Tung Univ, Brain Res Ctr, Taipei 11221, Taiwan
[7] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung 40705, Taiwan
关键词
Leber's hereditary optic neuropathy; LHON; whole exome sequencing; nuclear modifier genes; CONTAINING PROTEIN-1 FAHD1; MITOCHONDRIAL-DNA; ADENYLATE KINASE; MUTATION; IDENTIFICATION; LOCUS; POLYMORPHISMS; HETEROPLASMY; EXPRESSION; PEDIGREES;
D O I
10.3390/ijms231911891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leber's hereditary optic neuropathy (LHON) is a maternally transmitted disease caused by mitochondria DNA (mtDNA) mutation. It is characterized by acute and subacute visual loss predominantly affecting young men. The mtDNA mutation is transmitted to all maternal lineages. However, only approximately 50% of men and 10% of women harboring a pathogenic mtDNA mutation develop optic neuropathy, reflecting both the incomplete penetrance and its unexplained male prevalence, where over 80% of patients are male. Nuclear modifier genes have been presumed to affect the penetrance of LHON. With conventional genetic methods, prior studies have failed to solve the underlying pathogenesis. Whole exome sequencing (WES) is a new molecular technique for sequencing the protein-coding region of all genes in a whole genome. We performed WES from five families with 17 members. These samples were divided into the proband group (probands with acute onset of LHON, n = 7) and control group (carriers including mother and relative carriers with mtDNSA 11778 mutation, without clinical manifestation of LHON, n = 10). Through whole exome analysis, we found that many mitochondria related (MT-related) nuclear genes have high percentage of variants in either the proband group or control group. The MT genes with a difference over 0.3 of mutation percentage between the proband and control groups include AK4, NSUN4, RDH13, COQ3, and FAHD1. In addition, the pathway analysis revealed that these genes were associated with cofactor metabolism pathways. Family-based analysis showed that several candidate MT genes including METAP1D (c.41G > T), ACACB (c.1029del), ME3 (c.972G > C), NIPSNAP3B (c.280G > C, c.476C > G), and NSUN4 (c.4A > G) were involved in the penetrance of LHON. A GWAS (genome wide association study) was performed, which found that ADGRG5 (Chr16:575620A:G), POLE4 (Chr2:7495872T:G), ERMAP (Chr1:4283044A:G), PIGR (Chr1:2069357C:T;2069358G:A), CDC42BPB (Chr14:102949A:G), PROK1 (Chr1:1104562A:G), BCAN (Chr 1:1566582C:T), and NES (Chr1:1566698A:G,1566705T:C, 1566707T:C) may be involved. The incomplete penetrance and male prevalence are still the major unexplained issues in LHON. Through whole exome analysis, we found several MT genes with a high percentage of variants were involved in a family-based analysis. Pathway analysis suggested a difference in the mutation burden of MT genes underlining the biosynthesis and metabolism pathways. In addition, the GWAS analysis also revealed several candidate nuclear modifier genes. The new technology of WES contributes to provide a highly efficient candidate gene screening function in molecular genetics.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Leber's Hereditary Optic Neuropathy Precipitated by Ethambutol
    Asako Ikeda
    Tomohiro Ikeda
    Naohiro Ikeda
    Yoshimi Kawakami
    Osamu Mimura
    Japanese Journal of Ophthalmology, 2006, 50 : 280 - 283
  • [42] LEBER'S HEREDITARY OPTIC NEUROPATHY IN BULGARIAN PATIENTS
    Cherninkova, Sylvia
    Zaharova, Boryana
    Saraeva, Radoslava
    Todorova, Albena
    Kaneva, Radka
    Oscar, Alexander
    Tournev, Ivailo
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2020, 73 (01): : 125 - 132
  • [43] Idebenone: A Review in Leber's Hereditary Optic Neuropathy
    Lyseng-Williamson, Katherine A.
    DRUGS, 2016, 76 (07) : 805 - 813
  • [44] Idebenone Treatment In Leber's Hereditary Optic Neuropathy
    Carelli, Valerio
    La Morgia, Chiara
    Valentino, Maria Lucia
    Rizzo, Giovanni
    Carbonelli, Michele
    De Negri, Anna Maria
    Sadun, Federico
    Carta, Arturo
    Guerriero, Silvana
    Simonelli, Francesca
    Sadun, Alfredo Arrigo
    Aggarwal, Divya
    Liguori, Rocco
    Avoni, Patrizia
    Baruzzi, Agostino
    Zeviani, Massimo
    Montagna, Pasquale
    Barboni, Piero
    BRAIN, 2011, 134
  • [45] Late onset Leber's hereditary optic neuropathy
    Demidenko, Alexander
    Vakili, Roya
    Eggenberger, Eric R.
    Kaufman, David I.
    NEURO-OPHTHALMOLOGY, 2008, 32 (01) : 41 - 42
  • [46] Clinical spectrum of Leber's hereditary optic neuropathy
    Kerrison, JB
    Newman, NJ
    CLINICAL NEUROSCIENCE, 1997, 4 (05) : 295 - 301
  • [47] Is Leber's hereditary optic neuropathy a retinal disorder?
    Bynke, H
    Bynke, G
    Rosenberg, T
    NEURO-OPHTHALMOLOGY, 1996, 16 (02) : 115 - 123
  • [48] Leber's hereditary optic neuropathy precipitated by ethambutol
    Ikeda, A
    Ikeda, T
    Ikeda, N
    Kawakami, Y
    Mimura, O
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2006, 50 (03) : 280 - 283
  • [49] Medical treatments in Leber's hereditary optic neuropathy
    Hage, R.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2022, 45 (08): : S24 - S31
  • [50] A new sequence variant in mitochondrial DNA associated with high penetrance of Russian Leber hereditary optic neuropathy
    Povalko, N
    Zakharova, E
    Rudenskaia, G
    Akita, Y
    Hirata, K
    Toyojiro, M
    Koga, Y
    MITOCHONDRION, 2005, 5 (03) : 194 - 199